Copyright
©The Author(s) 2023.
World J Psychiatry. Oct 19, 2023; 13(10): 714-723
Published online Oct 19, 2023. doi: 10.5498/wjp.v13.i10.714
Published online Oct 19, 2023. doi: 10.5498/wjp.v13.i10.714
Figure 4 Comparison between neuronal pentraxin 2 serum levels and different variables in patients with epilepsy and cognitive dysfunction.
A to E: Gender(A), education level (B), epilepsy type (C), epilepsy drug types (D), and treatment protocol (E). ECD: Epilepsy patients with cognitive dysfunction; NPTX2: Neuronal pentraxin 2; VPA: Valproate.
- Citation: Huang XF, Xu MX, Chen YF, Lin YQ, Lin YX, Wang F. Serum neuronal pentraxin 2 is related to cognitive dysfunction and electroencephalogram slow wave/fast wave frequency ratio in epilepsy. World J Psychiatry 2023; 13(10): 714-723
- URL: https://www.wjgnet.com/2220-3206/full/v13/i10/714.htm
- DOI: https://dx.doi.org/10.5498/wjp.v13.i10.714